|Base Year Market Size
|USD 380.30 Million
|Forecast Year Market Size
|USD 681.72 Million
|Fastest Growing Market
The global neonatal ventilator market size was valued at USD 380.30 million in 2021. It is expected to reach USD 681.72 million by 2030, growing at a CAGR of 6.7% during the forecast period (2022–2030).
Neonatal ventilators are artificial breathing assistance devices explicitly designed and primarily used to treat the failures or disorders of neonatal respiratory function. A neonatal patient is connected to a device through an endotracheal tube directly applied to the airway through a noninvasive (NIV) mask. In addition, it is used as a diagnostic instrument to measure any abnormalities in how the respiratory system functions. Invasive and noninvasive ventilators are the two categories of neonatal ventilators currently on the market. These neonatal ventilators are intended to supply neonates with artificial gas support in the form of gas delivery and gas extraction, primarily oxygen and carbon dioxide in their respective forms.
Demand for neonatal ventilators is expected to surge due to increased incidence of preterm births, respiratory disorders, and mortality rates in neonates. Preterm birth is one of the leading causes of neonate mortality due to respiratory failures in neonates. Preterm births occur more frequently than full-term births. In addition, babies born with a low birth weight are more likely to suffer from various health problems and require specialized neonatal care. Inadequate neonatal care, particularly regarding respiratory monitoring and nutrition consumption, contributes significantly to the high mortality rate associated with premature births.
Noninvasive neonatal ventilators increase oxygenation and alveolar ventilation, which increases the proportion of surviving newborns. In addition, these ventilators can increase patient compliance, speed up the healing process, lower the risk of infection, and shorten the time of hospital stays. Noninvasive neonatal ventilation is an essential tool for the management of acute as well as chronic respiratory failure in the context of home care and critical care settings. Therefore, developing noninvasive neonatal ventilators is a primary factor driving the market expansion.
In recent years, governments worldwide have increased their spending on healthcare. In addition, governments worldwide are teaming up with private businesses to fulfill the growing demand for neonatal and adult ventilators.
Some of the numerous variables anticipated to propel the growth of the global neonatal ventilator market throughout the analysis period include rising technological developments in the healthcare infrastructure and rising disposable income of individuals. The widespread adoption of newborn ventilators has also been facilitated by rising private investment from important market participants and increased awareness of treating chronic respiratory illnesses, further fueling market expansion.
The high cost of the current portable instruments is the main factor preventing market growth. Investing significant capital is necessary to incorporate innovative design elements and technological advances into these devices. In addition, the prices of the non-movable ventilators range widely depending on their size, technology, and features. Neonatal ventilators have a price tag ranging from USD 7,500 to USD 45,000. These ventilators also need to be operated, maintained, and repaired by personnel with a high level of expertise, contributing to these devices' overall cost. Consequently, it is anticipated that the high costs associated with neonatal ventilators will act as a barrier to expanding the global neonatal ventilator market.
The portability of neonatal ventilators has been significantly improved due to their miniaturization, making it easier to monitor a patient's condition at home, in the hospital, or while they are transported in an emergency. The increase in the trend of semiconductor and bioelectronics technology has supplemented the development of circuits that consume less power and smaller batteries. The portability of neonatal ventilators is improved by having batteries with a small size and a long backup time. As a result, these devices have gradually replaced traditional ventilators over the past few years. Due to this, the market has experienced an increased demand for sophisticated and portable neonatal ventilators. As a result, technological advancements, portability, and improved designs in neonatal ventilators are anticipated to present lucrative growth opportunities for the neonatal ventilator market throughout the forecast period.
The expansion of the neonatal ventilator market is anticipated to be aided by active government support for suitable infrastructure, increased public knowledge of respiratory treatments, and an increase in the accessibility of emergency care during the study period.
The global neonatal ventilator market is segmented into four regions, namely North America, Europe, Asia-Pacific, and LAMEA.
North America is the most significant revenue contributor and is estimated to reach USD 209.29 million by 2030, with a CAGR of 5.1% during the forecast period. North America holds the largest share due to the presence of cutting-edge neonatal intensive care unit (NICU) facilities, a rise in the number of new-borns with chronic respiratory failure, an increase in the number of hospitals and clinics outfitted with advanced neonatal ventilators, and the availability of portable neonatal ventilators. In addition, advancements in neonatal ventilation technologies, such as non-invasive procedures and currently utilized invasive ventilation, are anticipated to drive market growth in the region.
During the forecast period, the ventilator market in Europe is anticipated to expand at a considerable CAGR. Some major market drivers, including the high number of medical device makers in Europe and the sharp rise in coronavirus cases, are responsible for the industry's expansion. However, it is claimed that the detrimental physiological effects of ventilators on the human body limit market expansion.
During the anticipated period, it is anticipated that the Asia-Pacific neonatal ventilator market will expand quickly. The rapid increase in product consumption among clinical and hospital end users is largely to blame. A further boost to the market will come from quick expansions in the new facilities and increased investments in this industry.
|CARL Reiner GmbH Draegerwerk AG & Co. KGaA Fritz Stephan GmbH General Electric Company (GE Healthcare) Getinge AB Hamilton Medical AG Inspiration Healthcare Group PLC (SLE Limited) Medtronic PLC (COVIDIEN LTD.) Smiths Group PLC Vyaire Medical Inc.
|U.K. Germany France Spain Italy Russia Nordic Benelux Rest of Europe
|China Korea Japan India Australia Taiwan South East Asia Rest of Asia-Pacific
|Middle East and Africa
|UAE Turkey Saudi Arabia South Africa Egypt Nigeria Rest of MEA
|Brazil Mexico Argentina Chile Colombia Rest of LATAM
|Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports
The global neonatal ventilator market is segmented by type and end-user.
Based on type, the global market is bifurcated into invasive and non-invasive ventilators.
The invasive segment is the highest contributor to the market, growing at a CAGR of 6.3% during the forecast period. The invasive neonatal ventilator market is anticipated to expand significantly. The National Center for Biotechnology Information (NCBI) reports that respiratory distress syndrome (ARDS), caused by a lack of lung surfactants, is most common in premature infants. However, approximately one percent of newborn infants also experience RDS. In addition, preterm birth complications and birth asphyxia, also known as not breathing at birth, are the leading causes of death in newborns. The market's growth is driven by technological advancements in invasive neonatal ventilators and an increase in healthcare professionals' awareness of these devices.
High preterm births with respiratory disorders and mortality rates, increased public awareness, and technological advancements in noninvasive neonatal ventilation devices are all expected to contribute to the noninvasive neonatal ventilator market growth.
Based on end-user, the global market is segregated into hospitals and clinics.
The hospital segment is the most dominant and is expected to grow at a CAGR of 6.7% during the forecast period. This is because hospitals are expected to increase their adoption of advanced neonatal ventilators and the surge in the number of neonates admitted to hospitals. The market's growth is also fuelled by an increase in the number of hospitals and an increase in the number of preterm births associated with respiratory disorders. Numerous neonatal ventilation clinics are anticipated to generate lucrative growth opportunities. In addition, increased government support for the prevention and effective treatment of respiratory diseases and skilled practitioners in developed nations are anticipated to boost the market growth.